CLINICAL TRIALS PROFILE FOR VYEPTI
✉ Email this page to a colleague
All Clinical Trials for VYEPTI
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02559895 ↗ | A Multicenter Assessment of ALD403 in Frequent Episodic Migraine | Completed | Alder Biopharmaceuticals, Inc. | Phase 3 | 2015-09-01 | The purpose of this study is to assess ALD403 in the prevention of migraine headache in frequent episodic migraineurs. |
| NCT04965675 ↗ | A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine | Recruiting | H. Lundbeck A/S | Phase 3 | 2021-06-30 | To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine. |
| NCT05064397 ↗ | A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) | Recruiting | H. Lundbeck A/S | Phase 3 | 2021-09-17 | The main goal of this trial is to inform about long-term safety and tolerability of eptinezumab in participants with chronic cluster headache. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VYEPTI
Condition Name
Clinical Trial Locations for VYEPTI
Trials by Country
Clinical Trial Progress for VYEPTI
Clinical Trial Phase
Clinical Trial Sponsors for VYEPTI
Sponsor Name
